These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 18290877
1. Distinct role of adrenoceptor subtypes in cardiac adaptation to chronic pressure overload. Du XJ. Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):355-60. PubMed ID: 18290877 [Abstract] [Full Text] [Related]
2. Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction. Du XJ, Fang L, Gao XM, Kiriazis H, Feng X, Hotchkin E, Finch AM, Chaulet H, Graham RM. J Mol Cell Cardiol; 2004 Nov; 37(5):979-87. PubMed ID: 15522275 [Abstract] [Full Text] [Related]
3. Sympathetic alpha(2)-adrenoceptors prevent cardiac hypertrophy and fibrosis in mice at baseline but not after chronic pressure overload. Gilsbach R, Schneider J, Lother A, Schickinger S, Leemhuis J, Hein L. Cardiovasc Res; 2010 Jun 01; 86(3):432-42. PubMed ID: 20083574 [Abstract] [Full Text] [Related]
4. Sustained augmentation of cardiac alpha1A-adrenergic drive results in pathological remodeling with contractile dysfunction, progressive fibrosis and reactivation of matricellular protein genes. Chaulet H, Lin F, Guo J, Owens WA, Michalicek J, Kesteven SH, Guan Z, Prall OW, Mearns BM, Feneley MP, Steinberg SF, Graham RM. J Mol Cell Cardiol; 2006 Apr 01; 40(4):540-52. PubMed ID: 16516910 [Abstract] [Full Text] [Related]
5. Pressure overload causes cardiac hypertrophy in beta1-adrenergic and beta2-adrenergic receptor double knockout mice. Palazzesi S, Musumeci M, Catalano L, Patrizio M, Stati T, Michienzi S, Di Certo MG, Mattei E, Vitelli L, Marano G. J Hypertens; 2006 Mar 01; 24(3):563-71. PubMed ID: 16467660 [Abstract] [Full Text] [Related]
6. Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon. Klein G, Schaefer A, Hilfiker-Kleiner D, Oppermann D, Shukla P, Quint A, Podewski E, Hilfiker A, Schröder F, Leitges M, Drexler H. Circ Res; 2005 Apr 15; 96(7):748-55. PubMed ID: 15761199 [Abstract] [Full Text] [Related]
7. Heart adrenoceptor gene expression and binding sites in the human failing heart. Fischer V, Gabauer I, Tillinger A, Novakova M, Pechan I, Krizanova O, Kvetnanský R, Myslivecek J. Ann N Y Acad Sci; 2008 Dec 15; 1148():400-8. PubMed ID: 19120134 [Abstract] [Full Text] [Related]
8. Adrenergic pathways and left ventricular remodeling. Dorn GW. J Card Fail; 2002 Dec 15; 8(6 Suppl):S370-3. PubMed ID: 12555147 [Abstract] [Full Text] [Related]
9. Lack of JunD promotes pressure overload-induced apoptosis, hypertrophic growth, and angiogenesis in the heart. Hilfiker-Kleiner D, Hilfiker A, Kaminski K, Schaefer A, Park JK, Michel K, Quint A, Yaniv M, Weitzman JB, Drexler H. Circulation; 2005 Sep 06; 112(10):1470-7. PubMed ID: 16129800 [Abstract] [Full Text] [Related]
10. Cardiac alpha 1-adrenergic drive in pathological remodelling. Woodcock EA, Du XJ, Reichelt ME, Graham RM. Cardiovasc Res; 2008 Feb 01; 77(3):452-62. PubMed ID: 18032391 [Abstract] [Full Text] [Related]
11. Regulated overexpression of the A1-adenosine receptor in mice results in adverse but reversible changes in cardiac morphology and function. Funakoshi H, Chan TO, Good JC, Libonati JR, Piuhola J, Chen X, MacDonnell SM, Lee LL, Herrmann DE, Zhang J, Martini J, Palmer TM, Sanbe A, Robbins J, Houser SR, Koch WJ, Feldman AM. Circulation; 2006 Nov 21; 114(21):2240-50. PubMed ID: 17088462 [Abstract] [Full Text] [Related]
12. Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice. Bisognano JD, Weinberger HD, Bohlmeyer TJ, Pende A, Raynolds MV, Sastravaha A, Roden R, Asano K, Blaxall BC, Wu SC, Communal C, Singh K, Colucci W, Bristow MR, Port DJ. J Mol Cell Cardiol; 2000 May 21; 32(5):817-30. PubMed ID: 10775486 [Abstract] [Full Text] [Related]
13. Heterozygous alpha 2C-adrenoceptor-deficient mice develop heart failure after transverse aortic constriction. Gilsbach R, Brede M, Beetz N, Moura E, Muthig V, Gerstner C, Barreto F, Neubauer S, Vieira-Coelho MA, Hein L. Cardiovasc Res; 2007 Sep 01; 75(4):728-37. PubMed ID: 17597596 [Abstract] [Full Text] [Related]
14. Knockout of beta(1)- and beta(2)-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis. Kiriazis H, Wang K, Xu Q, Gao XM, Ming Z, Su Y, Moore XL, Lambert G, Gibbs ME, Dart AM, Du XJ. Br J Pharmacol; 2008 Feb 01; 153(4):684-92. PubMed ID: 18193078 [Abstract] [Full Text] [Related]
15. Differential cardiovascular regulatory activities of the alpha 1B- and alpha 1D-adrenoceptor subtypes. Chalothorn D, McCune DF, Edelmann SE, Tobita K, Keller BB, Lasley RD, Perez DM, Tanoue A, Tsujimoto G, Post GR, Piascik MT. J Pharmacol Exp Ther; 2003 Jun 01; 305(3):1045-53. PubMed ID: 12649302 [Abstract] [Full Text] [Related]
16. Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload. Grieve DJ, Byrne JA, Siva A, Layland J, Johar S, Cave AC, Shah AM. J Am Coll Cardiol; 2006 Feb 21; 47(4):817-26. PubMed ID: 16487851 [Abstract] [Full Text] [Related]